In contrast, enhanced miR-224 expression attenuated proliferation of MDA-MB-231 cells and growth of implanted breast cancers in vivo, but did not significantly change the frequency of CD44+CD24− CSCs in MDA-MB-231 cells. This evidence concerns the gene CD44 and breast cancer.